HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

DC-MelVac

a second generation melanoma vaccine (DC-Melvac) that consists of five human melanoma cell lines, a recombinant vaccinia virus that encodes for IL-2, as well as dendritic cells that have been programmed to recognize certain melanoma associated antigens; approved by FDA in Phase I clinical trials 2/2008
Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Aydin, Nebil: 3 articles (05/2007 - 07/2006)
2. Alam, Khorshed: 3 articles (05/2007 - 07/2006)
3. Wallack, Marc: 2 articles (05/2007 - 07/2006)
4. Montenegro, Grace: 2 articles (05/2007 - 12/2006)
5. Boyes, Christopher: 2 articles (12/2006 - 07/2006)
6. Jack, Angela: 2 articles (12/2006 - 07/2006)
7. Montenegro, G: 1 article (02/2008)
8. Kalani, A D: 1 article (02/2008)
9. Degliuomini, J: 1 article (02/2008)
10. Wallack, M K: 1 article (02/2008)

Related Diseases

1. Melanoma (Melanoma, Malignant)
2. Neoplasms (Cancer)

Related Drugs and Biologics

1. Antigens
2. Interleukin-2 (IL2)